Gorzelitz, Jessica S.
Stoller, Stefanie
Costanzo, Erin
Gangnon, Ronald
Koltyn, Kelli
Dietz, Amy Trentham
Spencer, Ryan J.
Rash, Joanne
Cadmus-Bertram, Lisa
Funding for this research was provided by:
University of Wisconsin Carbone Cancer Center (2P30CA014520-44)
American Cancer Society (IRG-15-213-51)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (1R03CA230965-01A1)
Article History
Received: 22 January 2021
Accepted: 4 July 2021
First Online: 25 July 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the University of Wisconsin-Madison’s Health Sciences Institutional Review Board (Protocol #2018–0953) and by the Carbone Comprehensive Cancer Center’s Protocol Review and Monitoring Committee (Protocol UW18013). Prior to enrollment of the first participant, the study was registered at clinicaltrials.gov (NCT03722030).
: Written informed consent was obtained from all individual participants included in the study.
: N/A
: The authors declare no competing interests.